Affiliation:
1. From the Cattedra di Oncologia Medica ed EmatologiaDipartimento di Oncologia ed Ematologia, Università di Modena, Modena, Italy.
Abstract
PURPOSE: To establish, in patients with breast cancer subjected to primary conventional chemotherapy and enrolled in a prospective study, the mobilizing effect of therapy on potentially neoplastic cells by means of a reverse transcriptase polymerase chain reaction (RT-PCR) assay for mRNA of maspin, a protein related to the serpin family of protease inhibitors.PATIENTS AND METHODS: Peripheral-blood samples were collected from 30 patients with histologically proven breast cancer before and 4 and 8 days after conventional chemotherapy for three consecutive courses. A total of 216 samples were screened for the presence of maspin mRNA by RT-PCR.RESULTS: Before therapy, all samples but one were negative. After chemotherapy, 11 patients (38%) had positive samples. No difference in the rate of positivity was observed between groups defined according to initial stage, type of chemotherapy, Ki-67–related proliferative activity, or CA 15.3 expression.CONCLUSION: Our results confirm that RT-PCR for maspin mRNA is a sensitive assay for the study of circulating potentially neoplastic mammary cells in patients with breast cancer. Moreover, our findings indicate a marked effect of conventional-dose chemotherapy on the mobilization of these cells in breast tumors. In our series of patients, this phenomenon does not seem to be associated with other known risk factors. Finally, the data suggest, without proving, an association between the presence of circulating maspin positive cells and a higher risk of disease progression. If this association could be confirmed, then the assay could have prognostic significance. However, larger confirmatory studies are necessary.
Publisher
American Society of Clinical Oncology (ASCO)
Reference26 articles.
1. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques [see comments]
2. Pantel K, Izbicki JR, Angstwurm M, et al: Immunocytochemical detection of bone marrow micrometastasis in operable non-small cell lung cancer. Cancer Res 53:1027,1993-1031,
3. Pelkey TJ, Frierson HF Jr, Bruns DE: Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. Clin Chem 42:1369,1996-1381,
4. Tumor cell contamination of peripheral blood stem cell transplants and bone marrow in high-risk breast cancer patients
5. Cote RJ, Beattie EJ, Chaiwun B, et al: Detection of occult bone marrow micrometastasis in patients with operable lung carcinoma. Ann Surg 4:415,1995-425,
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献